Residual Kidney Function: Implications in the Era of Personalized Medicine

被引:17
|
作者
Shafi, Tariq [1 ,2 ]
Mullangi, Surekha [1 ]
Toth-Manikowski, Stephanie M. [1 ]
Hwang, Seungyoung [1 ]
Michels, Wieneke M. [3 ]
机构
[1] Johns Hopkins Univ, Dept Med, Baltimore, MD USA
[2] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA
[3] Acad Med Ctr, Dept Med, Div Nephrol, Amsterdam, Netherlands
关键词
NATIONAL COOPERATIVE DIALYSIS; GLOMERULAR-FILTRATION-RATE; RENAL-FUNCTION; HEMODIALYSIS-PATIENTS; KT/V-UREA; CLEARANCE; MORTALITY; FUROSEMIDE; DIURETICS; REMOVAL;
D O I
10.1111/sdi.12587
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The association of residual kidney function (RKF) with improved outcomes in peritoneal dialysis and hemodialysis patients is now widely recognized. RKF provides substantial volume and solute clearance even after dialysis initiation. In particular, RKF provides clearance of non-urea solutes, many of which are potential uremic toxins and not effectively removed by conventional hemodialysis. The presence of RKF provides a distinct advantage to incident dialysis patients and is an opportunity for nephrologists to individualize dialysis treatments tailored to their patients' unique solute, volume, and quality of life needs. The benefits of RKF present the opportunity to personalize the management of uremia.
引用
收藏
页码:241 / 245
页数:5
相关论文
共 50 条
  • [1] Ethical implications of epigenetics in the era of personalized medicine
    Josep Santaló
    María Berdasco
    Clinical Epigenetics, 2022, 14
  • [2] Ethical implications of epigenetics in the era of personalized medicine
    Santalo, Josep
    Berdasco, Maria
    CLINICAL EPIGENETICS, 2022, 14 (01)
  • [3] Clinical Trials for Kidney Disease in the Era of Personalized Medicine
    Heerspink, Hiddo J. L.
    Kretzler, Matthias
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (08): : 1123 - 1126
  • [4] Management of metastatic kidney cancer in the era of personalized medicine
    Monzon, Jose G.
    Heng, Daniel Y. C.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2014, 51 (02) : 85 - 97
  • [5] Dentistry in an era of personalized medicine
    Samaranayake, Lakshman
    JOURNAL OF INVESTIGATIVE AND CLINICAL DENTISTRY, 2012, 3 (03) : 161 - 162
  • [6] Personalized medicine in the era of genomics
    Burke, Wylie
    Psaty, Bruce M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (14): : 1682 - 1684
  • [7] Personalized Medicine in Kidney Disease
    Gembillo, Guido
    Siligato, Rossella
    Santoro, Domenico
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (10):
  • [8] Precision Diagnosis for the Era of Personalized Medicine
    Huang, Lin
    Qian, Kun
    SMALL METHODS, 2020, 4 (04)
  • [9] The Role of Pathologists in the Era of Personalized Medicine
    Walk, Eric E.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2009, 133 (04) : 605 - 610
  • [10] Redefining Personalized Medicine in the Postgenomic Era
    Blanchet, Kevin D.
    BJU INTERNATIONAL, 2010, 105 (02)